Using a mouse model of tamoxifen-inducible liver cancer, it was shown that tumor antigen-specific CD8+ T cells taken from the TME early during tumorigenesis could be reinvigorated by PD-1 blockade or recall in an antigen-free host. The gene discussed is CD8A; the disease is neoplasm.